We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights Toyota Motor, Lockheed Martin, Chubb and Pro-Dex
Read MoreHide Full Article
For Immediate Release
Chicago, IL – August 1, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Toyota Motor Corp. (TM - Free Report) , Lockheed Martin Corp. (LMT - Free Report) , Chubb Ltd. (CB - Free Report) and Pro-Dex, Inc. (PDEX - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Stock Reports for Toyota, Lockheed Martin and Chubb
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Toyota Motor Corp., Lockheed Martin Corp. and Chubb Ltd., as well as a micro-cap stock Pro-Dex, Inc. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Toyota Motor’s shares have outperformed the Zacks Automotive - Foreign industry over the past year (+12.4% vs. -11.1%). The company’s robust lineup of trucks and sport utility vehicles is set to fuel sales. To capitalize on the global shift to environment-friendly vehicles, the auto giant is deepening its focus on manufacturing electric and hydrogen fuel-cell vehicles, which will bolster the company’s product competitiveness.
Toyota Motor aims to expand global sales of BEVs to 1.5 million units in 2026 and 3.5 million units a year by 2030. Toyota’s commitment to maximize shareholders value via dividends and buyback is also praiseworthy.
However, labor cost inflation is expected to continue to weigh on margins. Rising debt levels, along with high R&D expenses and capex, are set to play spoilsport. Also, Toyota expects sales in Japan to decrease, given the lower shipments of Daihatsu. Thus, the stock warrants a cautious stance now.
Shares of Lockheed Martin have outperformed the Zacks Aerospace - Defense industry over the past year (+19.1% vs. -4.4%). The company ended second-quarter 2024 on a solid note, with both its earnings and revenues surpassing their respective Zacks Consensus Estimate. Its broad product offerings allow it to secure major defense contracts, which, in turn, boosts its backlog count.
Lockheed remains the largest U.S. defense contractor with a steady order flow from its leveraged presence in the Army, Air Force, Navy and IT programs. The solid U.S. defense budgetary provisions should boost its business. Its products also witness a strong international demand.
However, Lockheed is facing performance issues concerning some of its products that may affect its results. Shortage of skilled labor may adversely impact Lockheed’s operating results. The sanctions imposed by China on Lockheed might also affect its business.
Chubb’s shares have outperformed the Zacks Insurance - Property and Casualty industry over the past year (+36.2% vs. +25.2%). The company’s suite of compelling products as well as services, focus on capitalizing on the potential of middle-market businesses and investments in various strategic initiatives pave the way for long-term growth.
Several distribution agreements have expanded its network, boosting its market presence. An impressive inorganic growth story helps to achieve a higher long-term return on equity. Chubb expects adjusted net investment income to be in the range of $1.57 billion to $1.63 billion per quarter in 2024.
Chubb boasts a strong capital position with sufficient cash generation capabilities that ensure steady payouts to investors. Second quarter EPS beat estimates. However, exposure to catastrophe loss induces underwriting volatility. Escalating expenses weigh on margin expansion.
Shares of Pro-Dex have outperformed the Zacks Medical - Dental Supplies industry over the past year (+12.9% vs. -1.7%). This microcap company with market capitalization of $69.48 million has demonstrated strong financial performance, with net sales increasing 10% year over year to $38.8 million for the nine months ended Mar 31, 2024, reflecting robust demand.
The acquisition of a new 25,000 sq. ft. manufacturing facility in Tustin, CA, boosts production capacity and supports future growth. Strategic alliances, such as a supply agreement with Monogram Orthopaedics, enhance market reach and revenue potential. Pro-Dex's strong balance sheet, with $3.2 million in cash and $5.2 million in operating cash flow, ensures financial stability.
Strong customer relationships, with repeat business from major customers accounting for 85% of net sales, provide a stable revenue stream. However, customer concentration risk, limited market diversification, high operating expenses and competitive pressures are notable headwinds.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights Toyota Motor, Lockheed Martin, Chubb and Pro-Dex
For Immediate Release
Chicago, IL – August 1, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Toyota Motor Corp. (TM - Free Report) , Lockheed Martin Corp. (LMT - Free Report) , Chubb Ltd. (CB - Free Report) and Pro-Dex, Inc. (PDEX - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Stock Reports for Toyota, Lockheed Martin and Chubb
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Toyota Motor Corp., Lockheed Martin Corp. and Chubb Ltd., as well as a micro-cap stock Pro-Dex, Inc. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Toyota Motor’s shares have outperformed the Zacks Automotive - Foreign industry over the past year (+12.4% vs. -11.1%). The company’s robust lineup of trucks and sport utility vehicles is set to fuel sales. To capitalize on the global shift to environment-friendly vehicles, the auto giant is deepening its focus on manufacturing electric and hydrogen fuel-cell vehicles, which will bolster the company’s product competitiveness.
Toyota Motor aims to expand global sales of BEVs to 1.5 million units in 2026 and 3.5 million units a year by 2030. Toyota’s commitment to maximize shareholders value via dividends and buyback is also praiseworthy.
However, labor cost inflation is expected to continue to weigh on margins. Rising debt levels, along with high R&D expenses and capex, are set to play spoilsport. Also, Toyota expects sales in Japan to decrease, given the lower shipments of Daihatsu. Thus, the stock warrants a cautious stance now.
(You can read the full research report on Toyota here >>>)
Shares of Lockheed Martin have outperformed the Zacks Aerospace - Defense industry over the past year (+19.1% vs. -4.4%). The company ended second-quarter 2024 on a solid note, with both its earnings and revenues surpassing their respective Zacks Consensus Estimate. Its broad product offerings allow it to secure major defense contracts, which, in turn, boosts its backlog count.
Lockheed remains the largest U.S. defense contractor with a steady order flow from its leveraged presence in the Army, Air Force, Navy and IT programs. The solid U.S. defense budgetary provisions should boost its business. Its products also witness a strong international demand.
However, Lockheed is facing performance issues concerning some of its products that may affect its results. Shortage of skilled labor may adversely impact Lockheed’s operating results. The sanctions imposed by China on Lockheed might also affect its business.
(You can read the full research report on Lockheed Martin here >>>)
Chubb’s shares have outperformed the Zacks Insurance - Property and Casualty industry over the past year (+36.2% vs. +25.2%). The company’s suite of compelling products as well as services, focus on capitalizing on the potential of middle-market businesses and investments in various strategic initiatives pave the way for long-term growth.
Several distribution agreements have expanded its network, boosting its market presence. An impressive inorganic growth story helps to achieve a higher long-term return on equity. Chubb expects adjusted net investment income to be in the range of $1.57 billion to $1.63 billion per quarter in 2024.
Chubb boasts a strong capital position with sufficient cash generation capabilities that ensure steady payouts to investors. Second quarter EPS beat estimates. However, exposure to catastrophe loss induces underwriting volatility. Escalating expenses weigh on margin expansion.
(You can read the full research report on Chubb here >>>)
Shares of Pro-Dex have outperformed the Zacks Medical - Dental Supplies industry over the past year (+12.9% vs. -1.7%). This microcap company with market capitalization of $69.48 million has demonstrated strong financial performance, with net sales increasing 10% year over year to $38.8 million for the nine months ended Mar 31, 2024, reflecting robust demand.
The acquisition of a new 25,000 sq. ft. manufacturing facility in Tustin, CA, boosts production capacity and supports future growth. Strategic alliances, such as a supply agreement with Monogram Orthopaedics, enhance market reach and revenue potential. Pro-Dex's strong balance sheet, with $3.2 million in cash and $5.2 million in operating cash flow, ensures financial stability.
Strong customer relationships, with repeat business from major customers accounting for 85% of net sales, provide a stable revenue stream. However, customer concentration risk, limited market diversification, high operating expenses and competitive pressures are notable headwinds.
(You can read the full research report on Pro-Dex here >>>)
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.